Brand-Specific Enhanced Safety Surveillance Study of GSK’s Quadrivalent Seasonal Influenza Vaccine, Conducted During the COVID-19 Pandemic, in Belgium, Germany and Spain, for the 2020/21 Season-Reference-Cited by-同舟云学术

Brand-Specific Enhanced Safety Surveillance Study of GSK’s Quadrivalent Seasonal Influenza Vaccine, Conducted During the COVID-19 Pandemic, in Belgium, Germany and Spain, for the 2020/21 Season

Published:2021-12-27 Issue: Volume: Page:
ISSN:2193-8229
Container-title:Infectious Diseases and Therapy
language:en
Short-container-title:Infect Dis Ther

Author:

Dos Santos Gaël^ORCID,Wang Hao^ORCID,Jindal Pooja^ORCID,Rybo Maria^ORCID,Roul Hélène^ORCID,Pallem Sridevi^ORCID,Eckermann Tamara,Godderis Lode^ORCID,Martínez Gómez Xavier^ORCID,Godard Eric,Soler Muriel^ORCID,Yousefi Mitra^ORCID,Salamanca de la Cueva Ignacio^ORCID,Nwoji Ugo^ORCID

Funder

GlaxoSmithKline Biologicals SA

Publisher

Springer Science and Business Media LLC

Subject

Infectious Diseases,Microbiology (medical)

Link

https://link.springer.com/content/pdf/10.1007/s40121-021-00571-y.pdf

Reference31 articles.

1. European Centre for Disease Prevention and Control (ECDC). Factsheet about seasonal influenza. https://ecdc.europa.eu/en/seasonal-influenza/facts/factsheet. Accessed 1 Jul 2021.

2. Adlhoch C, Mook P, Lamb F, et al. Very little influenza in the WHO European region during the 2020/21 season, weeks 40 2020 to 8 2021 to 8 2021. Euro Surveill. 2020;26(11). https://doi.org/10.2807/1560-7917.ES.2021.26.11.2100221.

3. Andre FE, Booy R, Bock HL, et al. Vaccination greatly reduces disease, disability, death and inequity worldwide. Bull World Health Organ. 2008;86(2):140–6.

4. Baker RE, Park SW, Yang W, Vecchi GA, Metcalf CJE, Grenfell BT. The impact of COVID-19 nonpharmaceutical interventions on the future dynamics of endemic infections. Proc Natl Acad Sci USA. 2020;117(48):30547–53.

5. Ray R, Dos Santos G, Buck PO, et al. A review of the value of quadrivalent influenza vaccines and their potential contribution to influenza control. Hum Vaccin Immunother. 2017;13(7):1640–52.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enhanced Safety Surveillance of GSK’s Inactivated Quadrivalent Seasonal Influenza Vaccine in Belgium, Germany, and Spain During the 2022/2023 Influenza Season;Drug Safety;2024-06-29

2. An 8-Year Prospective, Observational, Multi-centre Post-Marketing Safety Surveillance Study Conducted in South Korea (2014–2022) Following the Introduction of GSK’s Inactivated Quadrivalent Seasonal Influenza Vaccine (Fluarix Tetra) for Subjects Aged 6 Months and Older;Drug Safety;2024-03-14

3. Enhanced safety surveillance of GSK's quadrivalent seasonal influenza vaccine in Germany and Spain (2021/2022 season) using an electronic patient‐reported outcome system for vaccine safety remote monitoring;Influenza and Other Respiratory Viruses;2023-03

4. No safety signals for GSK quadrivalent influenza vaccine;Reactions Weekly;2022-01